(Q34251032)

English

Comparative assessment of 5 methods (methylation-specific polymerase chain reaction, MethyLight, pyrosequencing, methylation-sensitive high-resolution melting, and immunohistochemistry) to analyze O6-methylguanine-DNA-methyltranferase in a series of

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Comparative assessment of 5 methods (methylation-specific polymerase chain reaction, MethyLight, pyrosequencing, methylation-sensitive high-resolution melting, and immunohistochemistry) to analyze O6-methylguanine-DNA-methyltranferase in a series of (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

immunohistochemistry

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Dominique Figarella-Branger

13

object named as

Dominique Figarella-Branger

0 references

Lucie Karayan-Tapon

3

object named as

Lucie Karayan-Tapon

0 references

object named as

Olivier Chinot

7

1 reference

ORCID Public Data File 2021

12

object named as

Marc Sanson

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

author name string

Véronique Quillien

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Audrey Lavenu

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Catherine Carpentier

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Marianne Labussière

5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Thierry Lesimple

6

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Michel Wager

8

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Jérome Honnorat

9

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Stephan Saikali

10

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Frédéric Fina

11

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

language of work or name

0 references

publication date

31 January 2012

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

118

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

4201-4211

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27392

7 January 2021

based on heuristic

inferred from DOI database lookup

MGMT promoter methylation in malignant gliomas: ready for personalized medicine?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27392

7 January 2021

based on heuristic

inferred from DOI database lookup

A distinct region of the MGMT CpG island critical for transcriptional regulation is preferentially methylated in glioblastoma cells and xenografts.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27392

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of regions correlating MGMT promoter methylation and gene expression in glioblastomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27392

7 January 2021

based on heuristic

inferred from DOI database lookup

MGMT gene silencing and benefit from temozolomide in glioblastoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27392

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic significance of molecular markers and extent of resection in primary glioblastoma patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27392

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27392

7 January 2021

based on heuristic

inferred from DOI database lookup

O(6)-methylguanine DNA-methyltransferase methylation status can change between first surgery for newly diagnosed glioblastoma and second surgery for recurrence: clinical implications

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27392

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27392

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic value of O6-methylguanine-DNA methyltransferase status in glioblastoma patients, assessed by five different methods

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27392

7 January 2021

based on heuristic

inferred from DOI database lookup

Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27392

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic impact of O6-methylguanine-DNA methyltransferase silencing in patients with recurrent glioblastoma multiforme who undergo surgery and carmustine wafer implantation: a prospective patient cohort.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27392

7 January 2021

based on heuristic

inferred from DOI database lookup

Validation of real-time methylation-specific PCR to determine O6-methylguanine-DNA methyltransferase gene promoter methylation in glioma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27392

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationship between expression of O6-methylguanine-DNA methyltransferase, glutathione-S-transferase π in glioblastoma and the survival of the patients treated with nimustine hydrochloride: An immunohistochemical analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27392

7 January 2021

based on heuristic

inferred from DOI database lookup

O6-methylguanine-DNA methyltransferase expression strongly correlates with outcome in childhood malignant gliomas: results from the CCG-945 Cohort

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27392

7 January 2021

based on heuristic

inferred from DOI database lookup

Pitfalls in the assessment of MGMT expression and in its correlation with survival in diffuse astrocytomas: proposal of a feasible immunohistochemical approach.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27392

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlation between O6-methylguanine-DNA methyltransferase and survival in inoperable newly diagnosed glioblastoma patients treated with neoadjuvant temozolomide

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27392

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of the promoter region of the human O6-methylguanine-DNA methyltransferase gene

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27392

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of breast cancer DNA methylation profiles with hormone receptor status and response to tamoxifen.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27392

7 January 2021

based on heuristic

inferred from DOI database lookup

Methylation-sensitive high resolution melting (MS-HRM): a new approach for sensitive and high-throughput assessment of methylation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27392

7 January 2021

based on heuristic

inferred from DOI database lookup

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27392

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival model predictive accuracy and ROC curves

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27392

7 January 2021

based on heuristic

inferred from DOI database lookup

Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27392

7 January 2021

based on heuristic

inferred from DOI database lookup

Comprehensive analysis of MGMT promoter methylation: correlation with MGMT expression and clinical response in GBM

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27392

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic significance of the immunohistochemical expression of O6-methylguanine-DNA methyltransferase, P-glycoprotein, and multidrug resistance protein-1 in glioblastomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27392

7 January 2021

based on heuristic

inferred from DOI database lookup

O6-Methylguanine DNA methyltransferase protein expression in tumor cells predicts outcome of temozolomide therapy in glioblastoma patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27392

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.27392

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34251032&oldid=2015154975"